Novel synthetic route to pyrido[2,3-b]indoles 189
117.5, 116.1, 114.6, 110.8, 96.2, 34.5. Anal. calcd for C19H13N3O:
C, 76.24; H, 4.38; N, 14.04. Found: C, 75.90; H, 4.34; N, 14.42.
References
Barun, O.; Patra, P. K.; Ila, H.; Junjappa, H. An expeditious synthesis
of substituted and annelated pyrido[2,3-b]indoles. Tetrahed. Lett.
1999, 40, 3797–3800.
Beccalli, E. M.; Clerici, F.; Marchesini, A. An alternative approach to
the synthesis of functionalized pyrido[2,3-b]indoles. Tetrahedron
2001, 57, 4787–4792.
Damavandi, S. New approach to the multicomponent one-pot syn-
thesis of 2-aryl-1H-phenanthro[9,10-d]imidazoles. Heterocycl.
Commun. 2011, 17, 79–81.
Dömling, A. Recent advances in isocyanide-based multicomponent
chemistry. Curr. Opin. Chem. Biol. 2002, 6, 306–313.
Hostyn, S.; Tehrani, K. A.; Lemiere, F.; Smout, V.; Maes, B. U. W.
Highly efficient one-pot synthesis of D-ring chloro-substituted
neocryptolepines via a condensation Pd-catalyzed intramolecular
direct arylation strategy. Tetrahedron 2011, 67, 655–659.
Menta, E.; Pescalli, N.; Spinelli, S. 1H-pirido[3,4-b]indol-1-one
derivavives. WO Pat. 2001; 2001/009129.
Meyer, M.; Guyot, M. Synthesis of 2-substituted indolo pyridin-4-
ones. Tetrahed. Lett. 1996, 37, 4931–4932.
Molina, P.; Fresneda, P. M.; Sanz, M. A. A new method for the for-
mation of the imidazo[4′,5′;3,4]pyrido[2,3-b]indole ring: formal
synthesis of the alkaloids from marine origin grossularines-1 and
2. Tetrahed. Lett. 1997, 38, 6909–6912.
Molina, P.; Fresneda, P. M.; Sanz, M. A.; Foces-Foces, C.; Ramirez,
D. A. MCR: investigative studies on the formation of the imidazo
[4′,5′:3,4]pyrido[2,3-b]indole ring: formal synthesis of the alka-
loids grossularines-1 and 2. X-ray crystal structures of 5-indol-3-
yl-imidazole and bisimidazocarbazole derivatives. Tetrahedron
1998, 54, 9623–9638.
Nicolaou, K. C.; Edmonds, D. J.; Bulger, P. G. Cascade reactions in
total synthesis. Angew. Chem. Int. Ed. Engl. 2006, 45, 7134–7186.
Nielsch, U.; Sperzel, M.; Bethe, B.; Junge, B.; Lieb, F.; Velten, R.
Treating tumor necrosis factor mediated inflammatory disease,
e.g. arteriosclerosis, using new or known beta-carboline deriva-
tives. 1999, DE Pat. 19807993 (A1).
Ritzeler, O.; Castro, A.; Grenler, L. Substituted SF Beta-carbolines as
lkB kinase inhibitors. 2001, EP Pat. 1134221 (A1).
Ryabova, S. Y.; Alekseeva, L. M.; Granik, V. G. Synthesis and some
transformationofderivativesofpyrido[3,2-b]indole(δ-Carboline).
Chem. Heterocycl. Compounds 2001, 37, 997–1004.
2,9-Dihydro-9-methyl-2-oxo-4-p-tolyl-1H-pyrido[2,3-b]indole-
3-carbonitrile (3) After 5 h the yield was 78%; IR: ν max 3254,
1
3119, 2976, 2835, 2218, 1647, 1551, 1422 cm-1; H NMR: δ 10.80
(1H, s, NHCO), 7.46 (1H, d, J=7.1 Hz, ArH), 7.57 (1H, d, J=7.1
Hz, ArH), 7.30–7.12 (6H, m, ArH), 3.52 (s, CH3, indole), 2.12 (s,
CH3); 13C NMR: δ 161.9, 156.1, 139.6, 135.5, 129.3, 128.7, 127.1,
125.9, 125.3, 124.0, 121.8, 120.1, 117.8, 115.1, 112.9, 95.2, 34.6,
24.9. Anal. calcd for C20H15N3O: C, 76.66; H, 4.82; N, 13.41. Found:
C, 76.49; H, 4.78; N, 13.38.
4-(4-Bromophenyl)-2,5-dihydro-2-oxo-1H-pyrido[3,2-b]indole-
3-carbonitrile (4) After 6 h the yield was 73%; IR: νmax 3246,
1
3125, 2983, 2826, 2217, 1656, 1509, 1452 cm-1; H NMR: δ 10.90
(1H, s, NHCO), 7.57 (1H, d, J=6.2 Hz, ArH), 7.40–7.30 (3H, m,
ArH), 7.15 (2H, d, J=6.4 Hz, ArH), 7.80 (2H, d, J=6.4 Hz, ArH),
3.55 (s, CH3, indole); 13C NMR: δ 168.5, 160.7, 139.2, 132.3, 129.5,
128.3, 127.9, 124.8, 124.1, 122.6, 121.8, 121.6, 117.3, 116.5, 111.3,
96.6, 32.7. Anal. calcd for C19H12BrN3O: C, 60.34; H, 3.20; N, 11.11.
Found: C, 60.21; H, 3.14; N, 11.05.
4-(2-Bromophenyl)-2,5-dihydro-2-oxo-1H-pyrido[3,2-b]indole-3-
carbonitrile (5) After 6 h the yield was 70%; IR: ν max 3255, 3134,
2991, 2806, 2228, 1650, 1544, 1487 cm-1; 1H NMR: δ 10.57 (1H, s,
NHCO), 7.60 (1H, d, J=7.0 Hz, ArH), 7.45–7.37 (2H, m, ArH), 7.22–
7.14 (5H, m, ArH), 3.63 (s, CH3, indole); 13C NMR: δ 163.3, 155.2,
139.7, 135.5, 132.1, 129.8, 125.9, 125.2, 124.6, 123.3, 121.9, 121.0,
118.8, 118.6, 118.1, 115.7, 94.1, 31.6. Anal. calcd for C19H12BrN3O:
C, 60.34; H, 3.20; N, 11.11. Found: C, 60.27; H, 3.13; N, 11.07.
4-(4-Chlorophenyl)-2,9-dihydro-9-methyl-2-oxo-1H-
pyrido[2,3-b]indole-3-carbonitrile (6) After 5.5 h the yield was
72%; IR: νmax 3263, 3115, 2980, 2802, 2212, 1652, 1535, 1470 cm-1;
1H NMR: δ 11.02 (1H, s, NHCO), 7.55 (1H, d, J=7.5 Hz, ArH), 7.46
(1H, d, J=7.7 Hz, ArH), 7.25–7.18 (4H, m, ArH), 7.04 (2H, d, J=7.7
Hz, ArH), 3.55 (s, CH3, indole); 13C NMR: δ 166.4, 161.1, 138.9,
135.3, 129.7, 127.4, 124.93, 124.7, 123.6, 122.1, 121.5, 120.5, 118.8,
116.7, 111.1, 93.6, 33.1. Anal. calcd for C19H12ClN3O: C, 68.37;
H, 3.62; N, 12.59. Found: C, 67.91; H, 3.53; N, 12.51.
Ryabova, S. Y.; Alekseeva, L. M.; Granik, V. G. Reduction of 2-ami-
no-1-(4-nitrophenyl)-1H-pyrido[3,2-b]indole-3-carbonitrile by
sodium borohydride and sodium cyanoborohydride. Russ. Chem.
Bull. Int. Ed. 2009, 58, 634–639.
Toure, B. B.; Hall, D. G. Natural product synthesis using multicom-
ponent reaction strategies. Chem. Rev. 2009, 109, 4439–4486.
Trost, B. M. Atom economy: a challenge for organic synthesis:
homogeneous catalysis leads the way. Angew. Chem. Int. Ed.
Engl. 1995, 34, 259–281.
Veale, C. A.; Damewood, J. R.; Steelman, G. B.; Bryant, C.; Gomes,
B.; Williams, J. Non-peptidic inhibitors of human leukocyte
elastase. 4. Design, synthesis, and in vitro and in vivo activity
of a series of β -carbolinone-containing trifluoromethyl ketones.
J. Med. Chem. 1995, 38, 86–97.
Wang, Z.; Zhou, L.; El-Boubbou, K.; Ye, X. -S.; Huang, X. Multi-
component one-pot synthesis of the tumor-associated carbohy-
drate antigen Globo-H based on preactivation of thioglycosyl
donors. J. Org. Chem. 2007, 72, 6409–6420.
4-(2-Chlorophenyl)-2,9-dihydro-9-methyl-2-oxo-1H-
pyrido[2,3-b]indole-3-carbonitrile (7) After 7 h the yield was
67%; IR: νmax 3250, 3142, 2997, 2812, 2211, 1667, 1553, 1465 cm-1;
1H NMR: δ 10.92 (1H, s, NHCO), 7.50 (1H, d, J=6.5 Hz, ArH), 7.43
(1H, d, J=6.5 Hz, ArH), 7.30–7.24 (2H, m, ArH), 7.20–7.05 (4H, m,
ArH), 3.60 (s, CH3, indole); 13C NMR: δ 169.5, 158.4, 139.7, 134.4,
131.1, 128.9, 125.5, 124.2, 122.9, 122.1, 120.8, 120.1, 118.9, 118.7,
116.9, 116.3, 98.5, 34.5. Anal. calcd for C19H12ClN3O: C, 68.37; H,
3.62; N, 12.59. Found: C, 67.84; H, 3.55; N, 12.49.
2,9-Dihydro-9-methyl-4-(4-nitrophenyl)-2-oxo-1H-pyrido[2,3-
b]indole-3-carbonitrile (8) After 8 h the yield was 65%; IR: νmax
3255, 3175, 2995, 2810, 2217, 1637, 1552, 1516, 1481, 1345 cm-1;
1H NMR: δ 10.85 (1H, s, NHCO), 8.09 (2H, d, J=7.2 Hz, ArH),
7.65–7.50 (3H, m, ArH), 7.40 (1H, d, J=7.7 Hz, ArH), 7.10 (2H, d,
J=7.7 Hz, ArH), 3.62 (s, CH3, indole); 13C NMR: δ 167.7, 159.2,
154.1, 148.3, 144.4, 129.9, 127.4, 125.9, 125.2, 123.3, 122.1, 121.7,
120.4, 119.5, 115.6, 114.1, 95.5, 34.6. Anal. calcd for C19H12N4O3:
C, 66.28; H, 3.51; N, 16.27. Found: C, 66.01; H, 3.42; N, 16.16.
Received August 10, 2011; accepted September 22, 2011;
previously published online October 20, 2011
Brought to you by | Universitaet Giessen
Authenticated
Download Date | 5/17/15 2:02 PM